美对中国输美产品再次加征10%关税，商务部回应！

Core Viewpoint - The U.S. has announced a 10% tariff on Chinese imports starting March 4, citing issues related to fentanyl, which China strongly opposes and plans to take countermeasures to protect its rights [1]. Group 1: U.S. Tariff Announcement - The U.S. imposed a 10% tariff on Chinese products, effective March 4, due to fentanyl-related issues [1]. - China expresses strong dissatisfaction and opposition to the U.S. decision, indicating it will take necessary countermeasures [1]. Group 2: China's Position on Drug Policy - China is recognized as one of the countries with the strictest and most thorough drug control policies globally [1]. - The cooperation between China and the U.S. on drug control has been extensive and has yielded significant results [1]. Group 3: Criticism of U.S. Actions - The U.S. is accused of shifting blame and acting unilaterally, disregarding facts and international trade rules [1]. - China's stance is that the U.S. tariffs violate World Trade Organization rules and undermine multilateral trade systems, which could harm U.S.-China economic cooperation and the normal international trade order [1]. - China urges the U.S. to respect the rights of other countries and to withdraw the unilateral tariff measures, advocating for a return to dialogue to resolve differences [1].